AFR: NeuroScientific targets Alzheimer’s cure

June, 2018

NeuroScientifc Biopharmaceuticals says the $5 million it's seeking to raise will fast track the development of an Alzheimer's treatment that the biotech reckons could be "one of the greatest drugs ever".

Read the original article

Further reading

September, 2022

Investor Update from NSB Chairman Paul Rennie

September, 2022

NeuroScientific Biopharmaceuticals Investor Update Webinar

December, 2021

NeuroScientific Biopharmaceuticals Investor Webinar Presentation – ShareCafe Small Cap “Hidden Gems”

November, 2021

Broker Briefing Webinar with Dr Alexandra Andrews

AFR: NeuroScientific targets Alzheimer’s cure

Subscribe for important NeuroScientific announcements and updates